Eleva Capital’s Edgewise Therapeutics EWTX Stock Holding History

Eleva Capital’s Portfolio EWTX Stock Details EWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-17,460	Closed	-$55K	–	33
2026 Q2	$55K	Hold	17,460	–	–	0.02%	23
2026 Q1	$55K	Buy	+17,460	New	+$503K	0.02%	23

Other funds holding EWTX

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Eleva Capital's EWTX Position: Q3 2026 in Review

Eleva Capital sold out of Edgewise Therapeutics (EWTX) in Q3 2026, closing a stake of 17,460 shares — an estimated $55K sold.

Eleva Capital first reported a position in EWTX in Q1 2026 and held it in 2 quarters. The position peaked at $55K in Q2 2026. 2 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.

Eleva Capital reported no remaining Edgewise Therapeutics position as of Q3 2026 after selling out during the quarter.
Eleva Capital sold 17,460 Edgewise Therapeutics shares in Q3 2026, an estimated $55K.
Eleva Capital first reported a position in Edgewise Therapeutics in Q1 2026 and held it in 2 quarters.
Eleva Capital's Edgewise Therapeutics position peaked at $55K in Q2 2026.
2 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.

Based on Eleva Capital's 13F filing for Q3 2026, filed 6 Oct 2026.